NASDAQ
Cosmo Pharmaceuticals N.V. (CMOPF) has a price/sales ratio of 17.25x as of Friday, May 22, 2026. This represents a 76.54% increase compared to its 12-month average of 9.77x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.